Correlation Between Zoetis and Orchestra BioMed
Can any of the company-specific risk be diversified away by investing in both Zoetis and Orchestra BioMed at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Zoetis and Orchestra BioMed into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Zoetis Inc and Orchestra BioMed Holdings, you can compare the effects of market volatilities on Zoetis and Orchestra BioMed and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Zoetis with a short position of Orchestra BioMed. Check out your portfolio center. Please also check ongoing floating volatility patterns of Zoetis and Orchestra BioMed.
Diversification Opportunities for Zoetis and Orchestra BioMed
-0.61 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Zoetis and Orchestra is -0.61. Overlapping area represents the amount of risk that can be diversified away by holding Zoetis Inc and Orchestra BioMed Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Orchestra BioMed Holdings and Zoetis is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Zoetis Inc are associated (or correlated) with Orchestra BioMed. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Orchestra BioMed Holdings has no effect on the direction of Zoetis i.e., Zoetis and Orchestra BioMed go up and down completely randomly.
Pair Corralation between Zoetis and Orchestra BioMed
Considering the 90-day investment horizon Zoetis is expected to generate 37.06 times less return on investment than Orchestra BioMed. But when comparing it to its historical volatility, Zoetis Inc is 3.85 times less risky than Orchestra BioMed. It trades about 0.0 of its potential returns per unit of risk. Orchestra BioMed Holdings is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest 751.00 in Orchestra BioMed Holdings on September 2, 2024 and sell it today you would lose (188.00) from holding Orchestra BioMed Holdings or give up 25.03% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Zoetis Inc vs. Orchestra BioMed Holdings
Performance |
Timeline |
Zoetis Inc |
Orchestra BioMed Holdings |
Zoetis and Orchestra BioMed Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Zoetis and Orchestra BioMed
The main advantage of trading using opposite Zoetis and Orchestra BioMed positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Zoetis position performs unexpectedly, Orchestra BioMed can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Orchestra BioMed will offset losses from the drop in Orchestra BioMed's long position.Zoetis vs. Emergent Biosolutions | Zoetis vs. Bausch Health Companies | Zoetis vs. Neurocrine Biosciences | Zoetis vs. Teva Pharma Industries |
Orchestra BioMed vs. Thai Beverage PCL | Orchestra BioMed vs. Aterian | Orchestra BioMed vs. Westrock Coffee | Orchestra BioMed vs. Keurig Dr Pepper |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Complementary Tools
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |